Safety and tolerability of 'Ready-to-Use' (SOMAKIT TOC (R)) 68Ga-DOTA0-Tyr3-Octreotide (68Ga-DOTATOC) for injection in patients with proven gastro-entero-pancreatic neuroendocrine tumours (GEP-NETs).
Manoharan, Prakash Navalkissoor, S Lamarca, Angela Calero-Valdayo, Jose Chan, P Sierra, M Caplin, M
Manoharan, Prakash
Navalkissoor, S
Lamarca, Angela
Calero-Valdayo, Jose
Chan, P
Sierra, M
Caplin, M
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2017
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Safety and tolerability of 'Ready-to-Use' (SOMAKIT TOC (R)) 68Ga-DOTA0-Tyr3-Octreotide (68Ga-DOTATOC) for injection in patients with proven gastro-entero-pancreatic neuroendocrine tumours (GEP-NETs). 2017, 105:170 Neuroendocrinology